Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™

03 September 2012

You may also like

23 May 2018

Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003)

24 March 2014

charmhealth names Gary Lakin as new CEO

17 December 2015

OneVentures’ Innovation and Growth Fund II hits $100 million in FUM

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

31 August 2016

OneVentures appoints Dr Graeme Wald to life sciences investment team

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor